The 2024 Global aHUS Poll Progress
When conceived it was known from previous experiences that having a global poll about aHUS was going to be a major…
When conceived it was known from previous experiences that having a global poll about aHUS was going to be a major…
What’s new in aHUS research? Quite a bit, if you consider that over four dozen publications have just been added to…
KDIGO met again to progress, through controversial means, knowledge of aHUS, or what ever it is called these days. There were…
This is a plain language summary of the final article to be published about Stopping Eculizumab Treatment Safely Clinical Trial. The…
Until eight years ago China had no policy on the care of people with rare diseases. There were discussions about it…
Keeping track of medical advancements in the rare disease space is challenging, but for those interested in atypical HUS the aHUS…
What is it like from an aHUS patients' perspective to decide to withdraw from complement inhibitor treatment? Much is published about…
A second article in a series of four planned has just been published. It is about the health economics of treatment…
The aHUS Alliance Global Action team remains strong advocates for those affected by the rare disease atypical HUS, and proudly partners…